DANAHER CORPORATION
Ownership & governance
Executives 5Directors 10Avg age 65Avg tenure 14y
RB
Rainer Blair
Chief Executive Officer
Age 62Since 2020-08-31Profile →
+14
Executives5
RB
Rainer Blair→
Chief Executive Officer
Age 62Since 2020-08-31
MG
Matthew Gugino
Director of Finance/CFO
—Since 2026-02-27
SD
Steven Dee
Chief Tech/Sci/R&D Officer
—Since 2025-08-24
SK
Sadik Kassim
Chief Tech/Sci/R&D Officer
—Since 2021-11-30
JG
Jose-Carlos Gutiérrez-Ramos→
Chief Tech/Sci/R&D Officer
Age 63Since 2020-12-31
Board of directors10
AS
Alan Spoon→
Director/Board Member
Age 74Since 1999-06-30
SR
Steven Rales→
Chairman
Age 74Since 1983-12-31
MR
Mitchell Rales→
Director/Board Member
Age 69Since 1983-12-31
LF
Linda Filler→
Director/Board Member
Age 66Since 2003-12-31
EZ
Elias Zerhouni→
Director/Board Member
Age 74Since 2009-12-10
TL
Teri List-Stoll→
Director/Board Member
Age 63Since 2011-08-31
RB
Rainer Blair→
Director/Board Member
Age 62Since 2020-08-31
RS
Raymond Stevens→
Director/Board Member
Age 62Since 2017-02-20
Shareholders4
| Name | Stake | Shares |
|---|---|---|
| Vanguard Capital Management LLC | 5.811 % | 41,127,810 |
| BlackRock Advisors LLC | 5 % | 35,386,981 |
| Steven Rales | 4.822 % | 34,126,240 |
| STATE STREET CORPORATION | 3.941 % | 27,894,181 |
Catalog · 2026-07-09
SEC officers22
| Name | Role | Since | Shares |
|---|---|---|---|
| Julie Sawyer Montgomery | President and Chief Executive Officer | — | 98,766 |
| Steven Rales | Chairman | — | - |
| A. Sanders | Director/Board Member | — | - |
| A. Shane Sanders | Director or executive officer | — | 9,036 |
| Alan G. Spoon | Director or executive officer | — | 105,815 |
| Alan Spoon | Director/Board Member | — | - |
| Charles W. Lamanna | Director or executive officer | — | 1,768 |
| Christopher P. Riley | Director or executive officer | — | 117,481 |
SEC · as of 2026-08-03
Group companies
| Name | Category |
|---|---|
| DH Europe Finance II SARL | Finance/Rental/Leasing |
| DH Europe Finance II SARL | Finance/Rental/Leasing |
| Beckman Coulter India Pvt Ltd. | Medical Specialties |
| Cepheid India Pvt Ltd. | — |
| Cepheid India Pvt Ltd. | — |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 244.14Range 200–310Analysts 22
200Mean 244.14310
- Strong buy 5
- Buy 17
- Hold 3
Broker actions40 of 302
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | 240 | 2026-10-13 |
| TD Cowen | Maintained | Buy | 255 | 2026-10-13 |
| Barclays | Maintained | Overweight | 255 | 2026-10-07 |
| RBC Capital | Maintained | Outperform | 250 | 2026-10-05 |
| Guggenheim | Maintained | Buy | 250 | 2026-10-01 |
| Wells Fargo | Maintained | Equal-Weight | 195 | 2026-07-22 |
| TD Cowen | Maintained | Buy | 236 | 2026-07-22 |
| Stifel | Maintained | Buy | 220 | 2026-07-22 |
| Guggenheim | Maintained | Buy | 200 | 2026-07-22 |
| RBC Capital | Maintained | Outperform | 215 | 2026-07-22 |
| Evercore ISI Group | Maintained | Outperform | 230 | 2026-07-06 |
| Piper Sandler | Initiated | Neutral | 200 | 2026-06-11 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.